Bio-Gene Technology

Bio-Gene Technology EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology (BGT.AX) as of Oct 20, 2026 is -3.41 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -3.03 M AUD — a change of 12.61% (lower).

EBITDA

-3.41 MAUD

YoY

12.61%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology is 2026 -3.41 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology was 2025 -3.03 M AUD. It decreases by 12.61% lower compared to the previous year.

The Bio-Gene Technology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-2.15 M AUD
Jan 1, 2020
-2.10 M AUD
Jan 1, 2021
-2.54 M AUD
Jan 1, 2022
-3.36 M AUD
Jan 1, 2023
-3.58 M AUD
Jan 1, 2024
-3.02 M AUD
Jan 1, 2025
-3.03 M AUD
Jan 1, 2026
-3.41 M AUD
The Bio-Gene Technology EBITDA history
YEAREBITDAYoY
-3.41 MAUD+12.61%
-3.03 MAUD+0.03%
-3.02 MAUD-15.59%
-3.58 MAUD+6.49%
-3.36 MAUD+32.25%
-2.54 MAUD+20.99%
-2.10 MAUD-2.02%
-2.15 MAUD-34.15%
-3.26 MAUD+192.13%
-1.12 MAUD+126.21%
-493,130.00AUD+192.48%
-168,602.00AUD+22.65%
-137,469.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-Gene Technology Stock analysis

What does Bio-Gene Technology do? Bio-Gene Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Gene Technology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology is -3.41 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology changed from -3.03 M AUD to -3.41 M AUD, representing a 12.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Bio-Gene Technology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Bio-Gene Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Bio-Gene Technology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bio-Gene Technology